MedTrace Logo

Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects

NCT03366389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2017-12-08

No results posted yet for this study

Summary

In this observational case-control study investigators aimed to assess the serum levels of adipokines such as Apelin, Chemerin and adiponectin in patients with irritable bowel syndrome (IBS), and compare it with healthy controls. Furthermore, investigators evaluated the possible correlation of these adipokines with IBS-QoL, IBSSS, GI symptoms and other clinical and psychological disorders.

Conditions

  • Irritable Bowel Syndrome

Sponsors & Collaborators

  • Lorestan University of Medical Sciences

    collaborator OTHER

  • Amir Abbasnezhad

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-07
Primary Completion
2017-09-16
Completion
2017-10-20

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366389 on ClinicalTrials.gov